Skip to main content
. 2016 Feb 5;11(4):1189–1193. doi: 10.3892/etm.2016.3047

Figure 2.

Figure 2.

Molecular events leading to cardiac and vascular dysfunction during reduced 1,25-dihydroxyvitamin D availability. Scheme showing different biochemical events underlying the clinical manifestations of vitamin D deficiency and reduced availability of 1,25-hydroxyvitamin D3. PTH, parathyroid hormone; MMP, matrix metalloproteinase; TNF-α, tumor necrosis factor-α; AGEs, advanced glycation end-products; ANP, atrial natriuretic peptide.